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Abstract 
Rationale, Aims and Objectives: PSYCHLOPS (‘Psychological Outcome Profiles’) is an idiographic patient-reported 
outcome measure that attempts to evaluate therapeutic progress. We aimed to assess the validity of PSYCHLOPS within a 
study of insomnia. 
Methods: We investigated reliability, content, criterion and construct validity of PSYCHLOPS as part of a cluster 
randomized pilot study. Other measures used included the Pittsburgh Sleep Quality Index, Insomnia Severity Index, Beck 
Depression Inventory and sleep diaries. We administered PSYCHLOPS in a study seeking to educate primary care 
clinicians to deliver problem-focused and patient-centred therapy for insomnia with adults. The instrument was 
administered in intervention and control primary care sites. Sixty two participants measuring 5 and above on the PSQI were 
included in the study. 
Results: The qualitative analysis showed expected responses for sleep problems. We found a positive correlation between 
PSYCHLOPS and ISI, but not between PSYCHLOPS and PSQI, suggesting partial criterion validity with regards to 
insomnia impact. We found a positive correlation between PSYCHLOPS and BDI supporting construct validity. However, 
these validity results rested on a number of assumptions insofar as patients who offered complex free text responses would 
have to rate their experiences at the beginning, midway and end of therapy respectively, in order for the tool to create a 
significant score. This would be difficult for patients to do, which undermines the tool’s validity. 
Conclusion: PSYCHLOPS demonstrated aspects of validity supporting further circumspect use and evaluation in practice. 
A combined qualitative and quantitative analysis added important dimensions to the assessment of validity for this tool. 
Nonetheless, idiographic measures like PSYCHLOPS provide a much needed patient voice to research and clinical outcome 
measures and are therefore important contributions to the development of person-centered medicine. 
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Introduction 
 
Various instruments, including Patient Reported Outcome 
Measures (PROMs) [1], have been validated for assessing 
sleep related interventions in clinical and research settings 
[2,3], but none are idiographic, that is, patient generated. 
Due to the eclectic nature of sleep problems [4], 
standardized measures may contain redundant or irrelevant 
items or miss salient aspects that are pertinent to a patient’s 
sleep problems [5]. Psychological Outcome Profiles 
(PSYCHLOPS) is different from other PROMs in 
incorporating patients’ own descriptions of their problems 
and meaning rather than pre-constructed statements 
developed from clinical diagnostic criteria [6].  
Insomnia, the most commonly reported psychological 
complaint in Britain [7], is often persistent [8] and 
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associated with physical problems as well as psychological 
sequelae [9,10]. It is also linked to impaired quality of life, 
poorer social and occupational functioning, work-related 
accidents [5], increased healthcare utilization and costs 
[11,12]. 
Hypnotic drug therapy is widely used, despite 
concerns about safety and limited evidence of its 
effectiveness [13-15]. Cognitive behavioral therapy for 
insomnia (CBT-I) has been shown to be at least as 
effective as drugs short term and safer long term for the 
management of persistent or recurrent insomnia [16] and 
for co-morbid insomnia associated with anxiety, 
depression, pain or cancer [17]. Although programs, such 
as Improving Access to Psychological Therapies (IAPT) 
[18] now provide better access to non-pharmacological 
therapies for conditions such as anxiety and depression, 
cognitive behavioral therapy for insomnia (CBT-I) is still 
not widely used or available mainly because of the lack of 
trained providers [19].  
PSYCHLOPS is primarily a mental health outcome 
measure and has not been used previously to assess sleep 
or sleep related-disorders. Whilst not originally developed 
for sleep problems, the PSYCHLOPS is a clinician 
administered tool, which has been shown to gather an array 
of narratives about mental health issues and which 
represents patients' voices within their personal and social 
contexts [6]. This personalized scoring questionnaire 
allows patients and professionals to evaluate progress 
before, during and following therapy by recording patients’ 
self-defined problems within a Free Text box, their 
severity and duration [20]. The tool also includes a general 
wellbeing question. All Free Text responses are also 
measured by patients on a Likert scale [21]. 
The current study represents one part of a larger study, 
the broad goal of which was to improve treatment for 
people suffering with sleep problems by promoting a range 
of treatment options beyond just hypnotics which are not 
always the most appropriate course of action and carry the 
risk of side effects and addiction. We administered 
PSYCHLOPS as part of a pilot study to assess whether 
intervention training of general practice clinicians (GPs 
and nurses) including ‘problem focused therapy,’ had any 
bearing on patient outcomes. In doing so, we aimed to 
assess and provide validity evidence of PSYCHLOPS 
through the reporting of baseline data addressing 
qualitative and quantitative validity dialectically. 
 
 
Methods 
 
Situating the study 
 
This study was part of a cluster randomized pilot study of a 
complex intervention [22]. Two primary care practices in 
Lincolnshire, UK were randomized to an educational 
intervention for problem focused therapy, which included a 
consultation approach to patients’ sleep problems and 
insomnia comprising of careful assessment including 
assessment of secondary causes, sleep diaries and use of 
modified Cognitive Behavior Therapy for Insomnia (CBT-
I) in the consultation. A control group at 2 different 
primary care practices in Lincolnshire, UK offered 
treatment as usual and were given sleep hygiene advice. A 
practice nurse administered PSYCHLOPS with other 
predetermined measures: the Pittsburgh Sleep Quality 
Index (PSQI) [3], Insomnia Severity Index (ISI) [2] and 
sleep diaries to assess sleep quality; Epworth Sleepiness 
Scale (ESS) for daytime sleepiness [23]; the Beck 
Depression Inventory (BDI) [24] and quality of life using 
EuroQoL EQ-5D [25] to adult patients. 
At the start of the therapy, data were collected using 
PSYCHLOPS that represent qualitative responses and 
scores on the 2 most important problems in respondents’ 
lives during the past week and any function that has been 
impaired due to these problems. During therapy, the initial 
problems identified by the patient on PSYCHLOPS are 
restated on a new form and patients are asked to rate these 
problems and functional domains again. There is an 
additional question at this stage, allowing patients to 
further identify and score a problem that may have 
surfaced during therapy. The end of treatment sheet is 
offered to the patient, with the same problems and 
functioning problem initially identified, in order to 
generate a final score. The quantitative data was analyzed 
separately from the qualitative data. 
We were interested in content validity (nature of 
response to items), internal validity (internal consistency or 
reliability), criterion validity (strength of relationship with 
a related variable) and construct validity (strength of 
relationship with an underlying variable) [26]. Quantitative 
data were analyzed using SPSS version 15. Qualitative 
data were analyzed using MAXQDA. Free-text data were 
open coded using as many codes as were deemed 
necessary to identify the properties and dimensions offered 
by the participants. Each case was open coded by 2 authors 
(ZD and HW) separately and then standardized following a 
number of coding sessions [6,27,28]. This approach 
enabled us to create codes that were linguistically the same 
or very similar to the patients’ responses to evaluate the 
tool idiographically. We wanted to identify 
phenomenologically important aspects of patients’ 
experiences and functioning that they were associating 
with their sleep problems. 
 
Participants 
 
In total, 62 participants, 34 women and 28 men all of 
whom measured 5 and above on the PSQI scale were 
administered PSYCHLOPS. Eighty-seven per cent of 
participants reported that they had had sleep problems for 
over 1 year and 43% said that they had lasted for more 
than 5 years. Sixty responses (33 women and 27 men) were 
used for the qualitative analysis (2 cases did not offer any 
free-text responses). In addition, 1 case did not answer 
question 1; 8 different cases did not answer question 2; 3 
different cases did not answer question 3 & 1 different case 
answered neither question 1 nor 2.  
The data from these cases were included, but coded as 
‘unanswered,’ so that we could determine if there were any 
similarities in relation to the types of data offered in the 
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adjacent questions. There did not appear to be any 
discernable patterns to the unanswered questions. 
We were granted ethics approval by Derbyshire 
Research Ethics Committee, UK. REC reference number: 
08/H0401/89. Informed consent was granted by all 
participants. 
 
 
Results 
 
Qualitative Content validity 
 
Content validity can have a non-statistical basis if it 
involves “the systematic examination of the test content to 
determine whether it covers a representative sample of the 
behavior domain to be measured” [29]. We examined 
content validity by investigating whether and to what 
extent the free-text responses related to clinical 
consultations for sleep problems including sleep problems 
themselves, their causes or consequences. In order to 
achieve this, the responses for question 1 were ‘open 
coded’ [28] into 26 codes and, for question 2, 30 codes. 
These codes were systematically organized, which 
generated 4 themes: sleep-related; psychological; 
sociological and physical. The third question was 
concerned with functioning and yielded 23 codes, which 
also corresponded to the 4 themes. 
 
Insomnia, sleep disturbance and related 
responses 
 
The majority of responses to question 1 did relate directly 
to sleep disturbances at night or tiredness. For example, 
“not continuous sleep” (Case 7), “sleeping” (Case 24) all 
seemed to relate well to the functioning problems stated. 
Items, such as “motivate myself” (Case 7),” “concentrate” 
(Case 24), “function/concentrating at work not 100%” 
(Case 29) and “socialising” (Case 9) were some of the 
statements. Although patients identified that sleep, 
tiredness and associated sleep disturbances were their main 
concern, they rarely expanded on this and their responses 
were kept to either single-word responses or at most a 
small number of words, such as “not being able to sleep” 
(Case 3), “Chronic Insomnia” (Case 19) or “disturbed 
sleep (when not taking tablets)” (Case 37). 
 
Sociological and psychological responses 
 
Sociological and psychological responses were often 
offered in more interdependent ways. Sociological data 
consisted of family concerns, such as bereavement, caring 
and relationship responsibilities, work related concerns, 
financial worries, isolation and loneliness and body image, 
all of which were coupled with emotional concerns, such 
as motivation, anxiety and stress. Stand-alone 
psychological responses often used diagnostic terms such 
as anxiety, stress and coping. However, a number of 
responses included sentiments such as, “live a normal life” 
(Case 47), “hard to feel good, feel less capable, not like me 
at all” (Case 61) and “being short tempered with children” 
(Case 24). 
 
Physical responses 
 
A small number of patients offered data about a physical 
condition that seemed to correspond well to their sleep 
problem and functioning problem. On these occasions, the 
physical problem would relate to some form of pain that 
disrupted their sleep. For example “Back problem” was 
associated with “not able to take long walks” (Case 38) 
and in other cases relating to functioning, they “[h]ad to 
stop gardening and hoovering and carrying heavy shopping 
bags” (Case 17). Nonetheless, it was difficult to ascertain if 
these patients were referring to their inability to do daily 
chores because of fatigue or because of the physiological 
inability or because of the pain. 
 
 
Complex and inter-related responses 
 
There were a number of responses that had to be 
qualitatively coded in a variety of domains due to the 
complexity of response. For example, “worries about my 
wife after heart by-pass; worried about my job and health 
problems; worries over my private life and my family” 
(Case 56) were coded as family, illness, other’s illness and 
work. The secondary and functioning questions in these 
cases were also more complex. Case 21 answered question 
1 with “[g]oing back to work and fulfilling my career” 
with a secondary problem defined as “[m]y relationship 
and how things over past 18 months have changed it 
[sleep?]” followed by the functioning response, which was 
“[k]now how to begin to be myself again.” Interestingly, 
one participant stated: “I have no problems that I am aware 
of” in response to questions 1 and 2 accompanied with 
“control the amount of pain from arthritis” (Case 14) as the 
functioning problem. 
 
Quantitative validity 
 
Table 1 shows the overall response rates and summary 
statistics of instruments used in the trial. PSYCHLOPS had 
the lowest completion rate (i.e., completion of all 
components for baseline and follow-up). The 
PSYCHLOPS, PSQI and ISI had the lowest relative 
variation, as measured by the coefficient of variation (0.27, 
0.27 and 0.31 respectively) which was also lower than the 
ESS (0.75) and BDI (0.58) instruments.  
There did not appear to be a relationship between sex 
or age and the scores generated by PSYCHLOPS. 
Table 2 shows the relative frequencies of the Likert-
scaled severity reported by respondents for the primary and 
secondary identified problems, difficulty performing a 
named task and self-rated wellbeing. Having named one 
thing that was hard to do because of the (named) problems, 
respondents were asked, “How hard has it been to do this 
thing over the last week?” Scores were skewed towards 
“Very Hard”; which was not surprising, since respondents 
were instructed already to select a task that was hard to do. 
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Despite this, 25% of respondents scored difficulty at the 
mid-point or below. 
 
Table 1 Summary statistics of the PSYCHLOPS, 
PSQI, ISI, ESSS and BDI instruments 
 
Score N Mean Standard deviation Minimum Maximum 
PSYCHLOPS 47 18.04 4.96 7 28 
PSQI 62 12.95 3.47 6 21 
ISI 60 16.97 5.25 4 26 
ESS 59 7.08 5.31 0 21 
BDI 60 13.80 8.00 0 30 
 
PSQI: Pittsburgh Sleep Quality Index; ISI: Insomnia Severity Index; ESI: 
Epworth Sleepiness Scale (ESS); Beck Depression Inventory (BDI). 
 
Table 2 Frequencies of PSYCHLOPS scores for 
problems 1 and 2, task difficulty and wellbeing 
 
 
How has 
(problem 1) 
affected 
you? 
 How has 
(problem  
2) 
affected 
you? 
Difficulty 
performing 
a named 
task  
Self 
rated 
feeling of 
well-
being 
 
Not at all/very good (0) 4 (6.7)* 6 (11.5) 5 (8.9) 7 (11.7) 
1 2 (3.3) 2 (3.9) 3 (5.4) 8 (13.3) 
2 7 (11.7) 7 (13.5) 8 (14.3) 11 (18.3) 
3 21 (35.0) 20 (38.5) 14 (25.0) 17 (28.3) 
4 13 (21.7) 9 (17.3) 8 (14.3) 13 (21.7) 
Very much/hard/bad (5) 13 (21.7) 8 (15.4) 18 (32.1) 4 (6.67) 
 
* N (%) 
 
Correlation between severity in the 2 problems, 
measured by Kendall’s tau [30] was 0.58 (p < 0.001). 
Difficulty felt performing the named task and the severity 
of problems 1 and 2, were moderately correlated with 
Kendall’s tau 0.58 (p < 0.001) and 0.48 (p < 0.001) 
respectively. Respondents were asked about wellbeing, 
“How have you felt in yourself this week?” Kendall’s tau 
between this self-rated feeling and the severity of problems 
1 and 2 was 0. 62 (p < 0.001) and 0.46 (p < 0.001) 
respectively. Kendall’s tau between self-rated feeling and 
the difficulty felt performing the named task was 0.58 (p < 
0.001). 
The findings suggested a moderately strong correlation 
between the severity of identified problems, the difficulty 
in performing an identified (and presumably related or 
relevant) task and self-rated feelings. The responses 
showed that the primary problem identified was correlated 
more strongly than the secondary problem with 
performance of the difficult task and how the respondent 
felt. 
 
Criterion validity 
 
Criterion or convergent, validity, was established by 
assessing the degree to which PSYCHLOPS correlated 
with other measures when this was theoretically expected 
[31], that is, PSQI and ISI. PSYCHLOPS did not correlate 
with PSQI (Kendall’s tau = 0.13, p = 0.24), but there was 
moderate correlation with ISI (Kendall’s tau = 0.47, 
p<0.001). Correlation between ISI and PSQI scores was 
also low (Kendall’s tau = 0.30, p = 0.001). However, the 
trial was not powered to establish such a correlation; the 
lack of correlation comparing PSCYHLOPS and PSQI 
could be a matter of sample size only. Both Figure 1 and 
Figure 2 illustrate non-scored (missing) data for several of 
the ISI and PSQI scores. 
 
Figure 1 Relationship between PSYCHLOPS and 
the PSQI 
 
 
Figure 2 Relationship between PSYCHLOPS and 
ISI scores 
 
 
Construct validity 
 
Construct validity is assessed according to how well an 
operationalized construct - in this case, a test/instrument 
developed from theory, truly measures that which the 
theory predicts. For testing construct validity we compared 
PSYCHLOPS with the BDI because sleep problems are 
often co-morbid with anxiety and depression [32].  
PSYCHLOPS and BDI were positively and 
statistically significantly correlated (Kendall’s tau = 0.47, 
p < 0.001). Moreover, BDI scores were also positively 
correlated with PSQI and ISI scores: Kendall’s tau 0.31 
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(p=0.001) and 0.41 (p<0.001), respectively. Therefore 
PSYCHLOPS demonstrated moderate evidence of criterion 
and construct validity. 
 
Figure 3 Relationship between PSYCHLOPS and 
BDI 
 
Discussion 
 
Qualitative responses usually related to the eclectic array 
of sleep problems and their (assumed) causes or 
consequences. In terms of quantitative validity, the 
correlations measured exceeded critical correlation 
coefficient thresholds for significance at these samples 
sizes, a necessary hurdle for validity. However, few of the 
correlations were strong and none for either criterion or 
construct validity exceeded 0.5. On this basis, we were 
able cautiously to validate the tool both quantitatively and 
qualitatively and found evidence that PSYCHLOPS could 
be used in sleep research and provides a patient-centered 
tool for clinical practice. There have been 2 published 
validation studies involving PSYCHLOPS in which the 
authors of the tool assessed criterion validity against the 
psychometric tools, Clinical Outcomes in Routine 
Evaluation - Outcome Measure (CORE-OM), which was 
constructed by a group of practitioners to assess patients’ 
psychological distress [33] and the Hospital Anxiety and 
Depression Scale (HADS) [34,35]. Completion rates were 
47% and 34% respectively and evidence was shown of 
convergent, concurrent and construct validity in these 
studies. These were quantitative validations, seeking 
accuracy, relevance and reliability of the tool. So far, the 
existing research has been based around the validity of 
PSYCHLOPS primarily as a mental health outcome 
measure and has not been used to assess sleep or sleep 
related-disorders. Since sleep problems and insomnia can 
occur as a result of varied causes, it is essential for 
clinicians to be able to evaluate the differential sleep 
problems to allow successful treatment planning [36]. 
 
Insights into validity testing 
 
Previous studies have sought to validate PSYCHLOPS 
quantitatively [34,35], independently from qualitative 
evaluations [6,20]. Conflicts between positivist and 
interpretive research philosophies arguably lead to 
incompatible formulations of validity and might pose a 
problem here [37]. Quantitative researchers would 
typically use statistical methods to compare a new 
instrument with existing measures [38]. It is obvious that 
qualitative tools cannot be validated using the same criteria 
[37,39,40]. Nonetheless, in the literature, there are broadly 
3 views pointing to how qualitative studies can be 
validated. There are those who wish qualitative research to 
be judged according to the same criteria as quantitative 
research, those who believe that a different set of criteria 
are required and those who question the appropriateness of 
any predetermined criteria (as is the case for quantitative 
validity) [41]. We took the view that the concept of 
‘validity’ could be used here for both approaches, since 
qualifying explanations are offered as to the philosophical 
and epistemological underpinning of the evaluation of 
validity that is discussed. We would argue that the 
evaluation of a tool, which combines qualitative and 
quantitative elements needs to integrate both 
epistemological approaches [38], because it will clarify the 
ways in which PSYCHLOPS may be utilized for sleep 
problem-focused therapy. 
There were no normative reference points for 
PSYCHLOPS, preventing comparison of patients’ 
responses at baseline. The use of free-text boxes allowed 
infinite ways of responding, creating problems for both 
qualitative and quantitative validity. Although the free-text 
box allowed space for a detailed explanation of an 
associated problem it was rarely used to offer in-depth 
insights into patients’ sleep problems. Often, a narrow 
range of words was used by patients and the brevity of 
response representing a brief summary of patient’s 
experience limited the extent to which the narratives could 
be analyzed as one would in a qualitative study, but 
simplified the quantitative analysis. 
Opposite to brevity, length may also cause problems 
for the validity of the tool, particularly in measuring 
patients’ interconnected problem(s) aggregately at the start, 
midway and end of the evaluation. To do so would have to 
rest on a number of assumptions. Firstly, analysis would 
have to assume that the patient pinpointed exactly what 
their foremost, secondary and functioning problems were 
prior to therapy and that these factors were causal and 
static in relation to their sleep problems. Secondly, the 
accuracy of patients’ evaluations and measurements when 
multiple factors are associated with the sleep problem is 
assumed. As we saw with case 56, the respondent would 
have to measure “Worries about my wife after heart by-
pass. Worried about my job and health problems. Worries 
over my private life and my family,” then remember how 
s/he felt and was experiencing this complexity at the 
midway and end point in order to offer any meaningful 
measurement. This, we would argue, is very difficult for 
respondents. Moreover, measurements at the midway and 
end point may have little to do with any therapy that is 
being offered and the tool could retrieve a better or worse 
score because of confounding factors, such as his/her 
spouse getting better or worse, a new manager at work who 
is more accommodating and so on. 
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According to some, patient-generated measures are 
instruments less well designed to measure both change 
over time (‘evaluative’) and discrimination 
(‘discriminative’) between 2 groups of patients [35]. 
According to the author of the tool, ‘maximising the 
evaluative attributes is likely to be achieved at the cost of 
diminishing the discriminative attributes. In relation to this, 
evaluative instruments are more likely to detect real 
clinical change but tend to have lower reliability’ [35]. 
This might undermine the idiographic nature of 
PSYCHLOPS that is claimed to be a strength [20]. Too 
little data may not allow meaningful phenomenological 
analysis whereas too much complexity could reduce 
reliability. PSYCHLOPS might be better administered 
after the first session of therapy, when various avenues 
have been explored and decisions made on which to focus 
on in the therapeutic sessions, since initial problems and 
related functioning are carried through at each stage and 
need to be consistent for the tool to work as it is intended 
to. 
The administration of the questionnaire may influence 
how patients complete it. Validity in a qualitative sense 
could depend on consistency of data retrieval through the 
research process. We were able to infer from the (missing) 
data that PSYCHLOPS was understood by patients and 
completed unaided or ‘interfered’ with by a researcher. 
Responses were in line with responses that would 
generally be understood as contributing to sleep problems 
or insomnia in general practice (Author, personal 
communication). Qualitative validity is concerned with 
descriptive, interpretive and theoretical validity as well as 
the accuracy and authenticity of data [41,42] and how 
these fit with existing theoretical models or inform new 
theory. Since thematic categories constructed from the data 
included psychological, physical and sociological 
experiences, which were different, but related to sleep and 
insomnia problems, we found this to be a positive aspect of 
the tool, but whether these can be accurately measured by 
PSYCHLOPS is debatable. 
 
Adding value to sleep therapy 
 
Researchers have argued that until healthcare professionals 
are able to use and evaluate PROMs that capture issues of 
importance to patients their potential will remain unknown 
[43]. Our findings offer a better understanding of 
PSYCHLOPS, how it facilitates inductive responses about 
patients’ experiences and a more person-centered measure 
of interconnected problems. 
 
Strengths and limitations 
 
We used PSYCHLOPS in the context of a pilot trial for 
management of insomnia. Data were collected in a 
standard way and were analyzed combining quantitative 
and qualitative approaches. Although the size of sample 
may not have been sufficient to show strong correlations 
between some measures and randomization in a fully 
powered study would equalize confounders across 
intervention and control groups, it was unlikely that 
positive results occurred by chance. However, it was also 
important that the correlation should not be perfect since 
then PSYCHLOPS would duplicate information from the 
ISI and PSQI tools, rather than provide a better tool to help 
clinicians to improve focus on salient concerns of patients. 
 
 
Conclusion 
 
PSYCHLOPS demonstrated qualified qualitative and 
quantitative validity and, because of its patient-centered 
approach, has potential to provide additional information 
to other measures in clinical practice and research settings. 
The arguments for meaningful validity, however, need to 
take into account the context in which the instrument is 
administered and potential conflicts between qualitative 
and quantitative notions of validity. Nonetheless, 
idiographic measures like PSYCHLOPS, which 
incorporate patients’ own descriptions of their problems 
and meanings, provide a much needed patient voice to 
research outcome measures. However, future evaluations 
of PSYCHLOPS for sleep-related problems and insomnia 
must consider whether the measure is a reflection of a 
patients’ condition or problems in order to arrive at a 
significant therapeutic assessment and outcome. Before 
this measure can be routinely used in sleep research it 
needs to be tested in diverse populations incorporating 
differences in language, age, disease status and educational 
level. 
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